St George’s, University of London to host free public event on the linguistics of power

St George’s, University of London in Tooting is hosting a free public event on 2 July 2013 to showcase new research on linguistics and explore possible personality traits of world leaders past and present.

Event: The Linguistics of Power

Professor George Griffin appointed to Public Health England board

St George’s, University of London’s Professor George Griffin has been appointed one of four new non-executive members of Public Health England’s (PHE) Advisory Board.

Professor Griffin joins another three new members on the seven-strong board of PHE, a new government organisation set up as the voice and expert service provider for national health. He was appointed by Jeremy Hunt, secretary of state for health.

Faculty retains top spots in latest NHS Health Education performance ratings

The Faculty of Health, Social Care and Education has received top marks from the NHS for the high quality of training it provides for nurses, midwives and allied health professionals.

NHS Health Education South London has rated the Faculty, run by Kingston University and St George’s, University of London, top in the capital for children’s nursing and diagnostic radiography in its latest contract performance management league tables. Adult nursing and physiotherapy also perform highly – ranked second in their respective categories – while therapeutic radiography is in third spot. Learning disability nursing and midwifery are each placed fourth.

St George’s team joins global consortium to tackle links between TB and diabetes

St George’s researchers have joined a new research consortium aiming to investigate the link between tuberculosis and diabetes, to develop better treatments for both diseases.

The TANDEM project – which is coordinated by the London School of Hygiene and Tropical Medicine – is a four-year collaborative research and innovation scheme that will provide new evidence on the links between diabetes and TB. This should lead to better strategies to control both diseases and improve patient care.

Drug resistance may make malaria parasites vulnerable to other substances

Malaria parasites that develop resistance to the most effective class of anti-malarial drugs may become susceptible to other treatments as a result. The discovery could reveal potential new drug options, which would be essential in the event of resistance to the best anti-malarials.

In a new study, researchers have shown how the anti-malarials artemisinins attack the malaria parasite by inhibiting the action of a crucial protein, and that genetic mutations in this protein can reduce the effect of the drugs. While demonstrating this, however, they also discovered that a mutation that gives the parasite resistance to artemisinins makes it more sensitive to attack by another substance, cyclopiazonic acid (CPA). CPA is thought to be too toxic to be a suitable anti-malarial treatment, but the findings suggest it could be worth pursuing derivatives of the acid as treatment options.